-
1
المؤلفون: Annie Latif, Arunima Mukhopadhyay, Mhairi Copland, Fiona Thomson, Dragana Milojkovic, Letizia Foroni, G. M. Smith, Jenny Byrne, Gillian A. Horne, Paolo Gallipoli, Philippe Schafhausen, Judith Dixon-Hughes, Franck E. Nicolini, P. Cony-Makhoul, Richard E. Clark, Wenjuan Cong, Gudmundur Vignir Helgason, Jon Stobo, Steffen Koschmieder, T H Brümmendorf, Lynn McMahon, Caroline Kelly, Tessa L. Holyoake
المصدر: Leukemia
LEUKEMIA
Horne, G, Stobo, J, Kelly, C, Mukhopadhyay, A, Latif, A, Dixon, J, McMahon, L, Cony-Makhoul, P, Byrne, J, Smith, G, Koschmieder, S, BrÜmmendorf, T, Schafhausen, P, Gallipoli, P, Thomson, F, Cong, W, Clark, R, Milojkovic, D, Helgason, V, Foroni, L, NICOLINI, F-E, Holyoake, T & Copland, M 2020, ' A randomised Phase II trial of Hydroxychloroquine and Imatinib versus Imatinib alone for patients with Chronic Myeloid Leukaemia in Major Cytogenetic Response with residual disease ', Leukemia . https://doi.org/10.1038/s41375-019-0700-9مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Fusion Proteins, bcr-abl, Disease, Chronic myeloid leukaemia, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Chloroquine, Internal medicine, hemic and lymphatic diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Aged, Retrospective Studies, business.industry, Cancer stem cells, Imatinib, Hydroxychloroquine, Hematology, Middle Aged, Translational research, Prognosis, Survival Rate, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cytogenetic Analysis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Female, Major Cytogenetic Response, Stem cell, business, Follow-Up Studies, medicine.drug
وصف الملف: application/pdf
-
2
المؤلفون: Vana Katsomitrou, Jad Othman, Justin Loke, Sylvie D. Freeman, Duncan Murray, Manish Jain, Behnaz Mobashwera, Renuka Palanicawandar, David Taussig, Michael J Austin, Anjum Bashir Khan, Charlotte Kallmeyer, Annie Latif, Alex Sternberg, Tom Taylor, Johnathon Elliot, Alex Bashford, Jamie Saunders, Seye Kolade, Michael Lim, Pramila Krishnamurthy, Edward Belsham, Sebastian Francis, John Laurie, Sreetharan Munisamy, Paolo Gallipoli, Charles Craddock, Cara Manson, Richard Dillon, Matthew Smith, Raymond Dang, Saniya Dhawan, Vidhya Murthy, Scott Marshall, Jennifer Byrne, Usman Afzal, Thomas Coats, Katherine Hodgson, Asim Khwaja, Michael Dennis, Ruebina Amofa, Katherine Smith
المصدر: Blood
مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, 615.Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies, Immunology, education, Gilteritinib, Cell Biology, Hematology, National health service, Biochemistry, Family medicine, Flt3 mutation, Pandemic, Medicine, Myeloid leukaemia, business, health care economics and organizations
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d797d712bf4e5bea81479d5a6643b9
http://europepmc.org/articles/PMC8701477 -
3
المؤلفون: Francesca Crolla, Charles Craddock, Paolo Gallipoli, Jesca Boot, Asim Khwaja, Vana Katsomitrou, Jad Othman, Annie Latif, Angela Collins, Ruebina Amofa, Raymond Dang, Justin Loke, Jamie Saunders, Cara Manson, Katherine Hodgson, Laura Anderson, Eleana Loizou, Alex Bashford, Mariam Amer, Sylvie D. Freeman, Pramila Krishnamurthy, Chris Dalley, Michael Dennis, Shahzad Orthi, Saniya Dhawan, Rui Zhao, Michael Lim, David Taussig, Matthew Smith, Anjum Bashir Khan, Sofia Galli, Tom Taylor, Richard Dillon, Richard Whitmill, Adam Rye, Charles Crawley, Pallavi Kalkur, Thomas Coats, Johnathon Elliott, Odong Ochaya, Victoria Louise Campbell, Dominika Radzova, John Laurie, Manish Jain, Deepak Mannari, Behnaz Mobashwera, Renuka Palanicawandar, Michael J Austin, Scott Marshall, Joe W Cross, Edward Belsham, Vidhya Murthy, Srinivas Pillai
المصدر: Blood
مصطلحات موضوعية: medicine.medical_specialty, 615.Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies, Venetoclax, business.industry, Immunology, Azacitidine, Low dose cytarabine, Cell Biology, Hematology, Intensive chemotherapy, National health service, Biochemistry, chemistry.chemical_compound, chemistry, Pandemic, Emergency medicine, medicine, business, Real world data, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5b58e0da2b4d8cb8360a2bff8d8454
https://doi.org/10.1182/blood-2021-149685 -
4
المؤلفون: Annie Latif, Amy Sinclair, Tessa L. Holyoake
المصدر: British Journal of Pharmacology. 169:1693-1707
مصطلحات موضوعية: Pharmacology, education.field_of_study, Autophagy, Population, Biology, medicine.disease, Leukemia, hemic and lymphatic diseases, Cancer research, medicine, Stem cell, Signal transduction, education, Tyrosine kinase, Protein kinase B, PI3K/AKT/mTOR pathway
Find this article in full text from Springer Verlag.